PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Premera Blue CrossCommercial · Prior Auth · Medical Policy · WA, AK · Oncology, Hematology, Ophthalmology +10 moreMedium impact

Medical Policy and Coding Updates - December 2022

Effective date
Apr 9, 2023
Identified
Jun 18, 2026

Summary

Botulinum toxin codes J0585, J0586, J0587 and J0588 require review for medical necessity and prior authorization for dates of service starting on and after December 1, 2022, under the temporomandibular joint disorder and hyperhidrosis policies. Coding changes effective December 1, 2022 also set C9142 to require medical necessity review, changed J0172 to require investigational review with prior authorization still required, and removed medical necessity review for A9593, A9594, A9595, A9596 and A9800. Drug policy updates added Botox, Dupixent for prurigo nodularis, Sotyktu for plaque psoriasis, and Vegzelma and Alymsys in the VEGF inhibitor policy.

Get alerts when payers change rules like this one

We check Premera Blue Cross and other payers every day and email you when a change matches your specialty and state.

Get Premera Blue Cross alertsPolicy Monitoring is free. No card required.

What to do

Action · 7 steps
01Already effective December 1, 2022: For dates of service starting on and after December 1, 2022, botulinum toxin codes J0585, J0586, J0587 and J0588 require review for medical necessity and prior authorization under the temporomandibular joint disorder and hyperhidrosis policies.
02Billing team: confirm prior authorization is in place for these codes before billing them.
03Already effective December 1, 2022: C9142 requires review for medical necessity under the VEGF inhibitor policy.
04J0172 no longer requires review for medical necessity, now requires review for investigational status, and still requires prior authorization.
05A9593, A9594, A9595, A9596 and A9800 no longer require medical necessity review, now require investigational review, and still require prior authorization.
06Already effective January 6, 2023: 90870 requires review for medical necessity and prior authorization under the InterQual criteria policy, and 27703 no longer requires review.
07Check current applicability of these dates before acting on them.

Codes mentioned

J0585J0586J0587J0588C9142J0172A9593A9594A9595A9596A98009087027703

Original notice

Medical Policy and Coding Updates - December 2022
premera.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account